
Sign up to save your podcasts
Or


How close are we to herd immunity and what could help us get there? In this podcast, we discuss the latest on the COVID-19 vaccine rollout, herd immunity, virus variants, as well as biotech advances in health care.
The views expressed are those of Diamond Hill as of February 2021 and are subject to change. These opinions are not intended to be a forecast of future events, a guarantee of results, or investment advice.
As of February 28, 2021, Diamond Hill owned shares of Pfizer, Inc and Roche Holdings AG.
By Diamond Hill Capital Mgmt5
2727 ratings
How close are we to herd immunity and what could help us get there? In this podcast, we discuss the latest on the COVID-19 vaccine rollout, herd immunity, virus variants, as well as biotech advances in health care.
The views expressed are those of Diamond Hill as of February 2021 and are subject to change. These opinions are not intended to be a forecast of future events, a guarantee of results, or investment advice.
As of February 28, 2021, Diamond Hill owned shares of Pfizer, Inc and Roche Holdings AG.

3,072 Listeners

1,173 Listeners

2,175 Listeners

1,993 Listeners

288 Listeners

797 Listeners

298 Listeners

9,535 Listeners

80 Listeners

95 Listeners

1,573 Listeners

435 Listeners

37 Listeners